PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation

• Published in: Cell death & disease 2023-07, Vol.14 (7), p.432-432, Article 432
• Main Authors: Du, Juan, Liu, Yahui, Lan, Gelei, Zhou, Yao, Ni, Yingmeng, Liao, Kai, Zheng, Fang, Cheng, Qijian, Shi, Guochao, Su, Xiao
• Format: Article
• Language: English
• Subjects: 13/31; 38/77; 45/29; 45/91; 631/250/1933; 64/60; 692/699/1785/31; 96/1; 96/109; 96/2; 96/21; 96/95; Animals; Antibodies; Asthma; Asthma - genetics; Asthma - metabolism; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Culture; DNA structure; Endothelial cells; Endothelial Cells - metabolism; Epithelial cells; Immunology; Inflammation; Inflammation - metabolism; Inflammatory diseases; Interleukin-33 - genetics; Kinases; Life Sciences; Macrophages; Macrophages - metabolism; MAP kinase; Mice; Necroptosis; Protein Kinases - metabolism; Pyroglyphidae; Respiratory tract; Respiratory tract diseases; Signal Transduction
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-023-05971-1

Polymerase 1 and transcript release factor (PTRF, encoding by Cavin-1 ) regulates interleukin 33 (IL-33) release, which is implicated in asthma development. Z-DNA binding protein 1 (ZBP1)-sensing Z-RNAs induces necroptosis which causes inflammatory diseases. House dust mite (HDM) is the major source of allergen in house dust and is strongly associated with the development of asthma. Whether PTRF via IL-33 and ZBP1 mediates HDM-induced macrophage necroptosis and airway inflammation remains unclear. Here, we found that deficiency of PTRF could reduce lung IL-33, ZBP1, phosphor-receptor-interacting protein kinase 3 (p-RIPK3), and phosphor-mixed lineage kinase domain-like (p-MLKL) (necroptosis executioner), and airway inflammation in an HDM-induced asthma mouse model. In HDM-treated macrophages, ZBP1, p-RIPK3, and p-MLKL levels were markedly increased, and these changes were reversed by deletion of Cavin-1 . Deletion of Il33 also reduced expression of ZBP1, p-RIPK3, and p-MLKL in HDM-challenged lungs. Moreover, IL-33 synergizing with HDM boosted expression of ZBP1, p-RIPK3, and p-MLKL in macrophages. In bronchial epithelial cells rather than macrophages and vascular endothelial cells, PTRF positively regulates IL-33 expression. Therefore, we conclude that PTRF mediates HDM-induced macrophage ZBP1/necroptosis and airway inflammation, and this effect could be boosted by bronchial epithelial cell-derived IL-33. Our findings suggest that PTRF-IL33-ZBP1 signaling pathway might be a promising target for dampening airway inflammation.